Profound Medical Unveils Q2 2024 Financials

TipRanks17:09 ET

Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow

TORONTO, July 18, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF, TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, incision-free

GlobeNewswire16:30 ET

Profound Medical Upgraded at Stifel on Medicare Policy Update

Seeking AlphaJul 16 14:45 ET

Profound Medical Shares Are Trading Higher After Stifel Upgraded the Stock From Hold to Buy.

Profound Medical Shares Are Trading Higher After Stifel Upgraded the Stock From Hold to Buy.

BenzingaJul 16 09:18 ET

Stifel Maintains Profound Medical(PROF.US) With Buy Rating, Maintains Target Price $12

Stifel analyst Rick Wise maintains $Profound Medical(PROF.US)$ with a buy rating, and maintains the target price at $12.According to TipRanks data, the analyst has a success rate of 58.0% and a

Moomoo NewsJul 16 08:33 ET · Ratings

Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Mizuho

BenzingaJul 16 08:05 ET